- 24/7 Wall St.•17 hours ago
August 29, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by about 7 to 3 and Nasdaq advancers ...
- TheStreet.com•19 hours ago
Piper Jaffray said in a note Monday that Gilead Sciences (GILD) likely won't be impacted by GlaxoSmithKline's (GSK) potential new two-drug HIV regimen.
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||78.02 x 900|
|Ask||78.10 x 300|
|Day's Range||77.63 - 79.70|
|52wk Range||77.63 - 113.31|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||6.86|
|Avg Vol (3m)||10,240,462|
|Dividend & Yield||1.88 (2.36%)|